Ichor Life Sciences is working to enable people to live longer, healthier lives. Aging affects everyone and is the cause for multiple diseases, yet there is no cure. As a contract research organization (CRO), Ichor is studying the fundamental mechanisms of aging to develop new classes of drugs. Ichor operates R&D laboratories in LaFayette and POtsdam, NY and offers two services. Ichor Discovery Services provide world-class protein manufacturing, structural biology, biophysics and assay development. Ichor Pharmacology Services focus on in vitro testing, histology and toxicology. Ichor serves to support and incubate projects regarding aging, oncology, metabolic disease and musculoskeletal disease. 

<p>Ichor Life Sciences is working to enable people to live longer, healthier lives. Aging affects everyone and is the cause for multiple diseases, yet there is no cure. As a contract research organization (CRO), Ichor is studying the fundamental mechanisms of aging to develop new classes of drugs. Ichor operates R&amp;D laboratories in LaFayette and POtsdam, NY and offers two services. Ichor Discovery Services provide world-class protein manufacturing, structural biology, biophysics and assay development. Ichor Pharmacology Services focus on in vitro testing, histology and toxicology. Ichor serves to support and incubate projects regarding aging, oncology, metabolic disease and musculoskeletal disease. </p>


Ichor Life Sciences


 
   
      
                 
            
               
                  Full Program
                  HOXA3 Accelerates Wound Healing in Diabetic and Aged Non-Diabetic Mammals
               
               
                  
                      K. Parella, K. Moody, D. Wortel, H. Colegrove & J. A. Elser
                  
               
            
         
      
   



Innovative program seeks to spark science careers - SUNY Cortland News

Company news: Christopher Schillo hired by Ichor Life Sciences - syracuse.com


              Cypris Therapeutics Launches as Newest Ichor Life Sciences Portfolio Company, Secures Over $500k in Pre-Seed Funding
            

Cypris Therapeutics Launches as Newest Ichor Life Sciences Portfolio Company, Secures Over $500k in Pre-Seed Funding - Business Wire


 
   
      
                    
            
               
                  Interplay of self-organization of microtubule asters and crosslinking protein condensates
               
               
                  
                     Sahu, S., Chauhan, P., Lumen, E., Moody, K., Peddireddy, K., Mani, N., Subramanian, R., Robertson-Anderson, R., Wolfe, A. J., Ross, J. L.
                     
                     July 2023                         PNAS Nexus                      
                  
               
            
         
      
   



Ichor Life Sciences Expands Clinical Trial Services - Contract Pharma


   
      
         
            
               
                  
                     
                        
                           
                                        
                        
                     
                     
                        Lento Bio, Inc. Appoints Two Ichor Life Sciences Executives as a Member of the Board of Directors and Scientific Advisors
                     
                     
                        
                             July 20, 2022
                        
                     
                  
               
            
         
      
     
     

NOVOS’ ingredient combination maintains DNA and targets senescence - Longevity.Technology


              Episode 16 - Dr. Kelsey Moody
            

Stay cool: the longevity tech that "shows insane promise" - Longevity.Technology

Amazing work from Lisa Sonneborn, MA, LMHC and the incredible clinical team at Ichor! 

Ichor Research is the newest addition to the Ichor umbrella, adding the execution of Phase I-IV human clinical trials to Ichor’s end-to-end service model.


 
   
      
                 
            
               
                  Technical Advancement
                  A Generalizable Nanopore Sensor for Highly Specific Protein Detection at Single-Molecule Precision.
               
               
                  
                      Ahmad, M., Ha, J.-H., Mayse, L., Presti, M., Wolfe, A. J., Moody, K. J., Loh, S. N., & Movileanu, L.
                  
               
            
         
      
   




   
      
         
            
               
                  
                     
                        
                           
                                        
                        
                     
                     
                        Ichor Life Sciences Announces Launch of Ichor Clinical Trial Services
                     
                     
                        
                             November 14, 2023
                        
                     
                  
               
            
         
      
     
     


              Lento Bio Expands Leadership Team with the Appointment of Two Renowned Ophthalmology and Presbyopia Experts
            


              Lento Bio Relocates to Syracuse, NY, Joining Ichor Life Sciences' New Biotech Incubator Facility
            


 
   
      
                    
            
               
                  Extracellular vimentin is sufficient to promote cell attachment, spreading, and motility by a mechanism involving N-acetyl glucosamine-containing structures
               
               
                  
                     Bucki, R., Iwamoto, D. V., Shi, X., Kerr, K. E., Byfield, F. J., Suprewicz, L., Sklodowski, K., Sutaria, J., Misiak, P., Wilczewska, A. Z., Ramachandran, S., Wolfe, A., Thanh, M. H., Whalen, E., Patteson, A. E., Janmey, P. A.
                     
                     June 2023                         Journal of Biological Chemistry                      
                  
               
            
         
      
   



Expanding homegrown biotech company to make $2.8 million move back into city of Syracuse - syracuse.com

CRO Ichor Life Sciences launches clinical trial services unit - Fierce Biotech

Dragon boats move to drumbeat, hundreds at growing festival - North Country Now

Micron fellow to speak at tech summit in Syracuse that will showcase emerging companies - syracuse.com

 CRO Ichor Life Sciences launches clinical trial services unit 

 Cypris Therapeutics Launches as Newest Ichor Life Sciences Portfolio Company, Secures Over $500k in Pre-Seed Funding 


              A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models | Nature Biotechnology
            


   
      
              
            
               
                  FEATURED NEWS
                  Ichor Life Sciences Expands Ichor Clinical to Australia, Europe, and UK
               
               
                  
                       January 24, 2024
                  
               
            
         
      
   
 

Robust Mouse Rejuvenation project details announced - Longevity.Technology

Exciting news! Congratulations to our newest portfolio company, Cypris Therapeutics, Inc., for taking 1st Prize at the Florida State University Discovery Challenge and securing $60K in nondilutive funding! 

 Expanding homegrown biotech company to make $2.8 million move back into city of Syracuse 

Thank you to Scrip Asks for letting me share my thoughts about what's to come for CROs in 2024! If you don't pay for it you can get a free trial (do it!). 

https://lnkd.in/edfWZagP

Recently, we shared a short video that introduced our fantastic collaboration with Ichor Life Sciences, Inc. and the core service offerings of both businesses.  Today, our Founder and Director, A/Prof Tina Soulis ALITHIA LIFE SCIENCES (CRO), and President of Clinical Trial Services at Ichor Clinical, Lisa Sonneborn, MA, LMHC, outline the reasons why it made perfect sense for Alithia and Ichor to join forces.

#lifesciences #lifesciencesindustry #clinicaltrials #clinicalresearch #contractresearchorganization #collaboration #partnership #spirit #culture #integrity #australia #unitedstates


              Expanding homegrown biotech company to make $2.8 million move back into city of Syracuse
            

Ichor Life Sciences

Business:

About: